Extracorporeal membrane oxygenation (ECMO) is life-saving for potentially reversible heart
failure and respiratory injuries not responsive to conventional therapies. Technological …

Veno-arterial extracorporeal membrane oxygenation (VA ECMO) is widely used in
cardiogenic shock. It provides systemic perfusion, but left ventricular (LV) unloading is …

Aims Heart transplantation (HT) can be proposed as a therapeutic strategy for patients with
severe refractory electrical storm (ES). Data in the literature are scarce and based on case …

Aims Primary graft dysfunction (PGD) is a feared complication after heart transplantation
(HTX). HTX patients frequently receive veno‐arterial extracorporeal membrane oxygenation …

Severe primary graft dysfunction (PGD) is the leading cause of early postoperative mortality
following orthotopic heart transplantation (OHT). Veno-arterial extracorporeal membrane …

OBJECTIVES Survival after heart transplantation is steadily improving but primary graft
dysfunction (PGD) is still a leading cause of death. Medical management seems useful in …

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) supports patients suffering
from refractory cardiogenic shock. Thromboembolic complications (TeC) are common in VA …

Heart transplantation (HTx) is a valuable option in eligible patients with end-stage heart
failure. The most significant complication in the immediate post-operative period is early …

Background The occurrence of early graft failure (EGF) after heart transplantation (Htx) often
requires a mechanical circulatory support (MCS) therapy. The aims of our study were to …

Primary graft dysfunction (PGD) is a rare complication associated with high mortality after
heart transplantation, which may require veno-arterial extra-corporeal membrane …